Health
100 Most Popular
Most Popular Under $25
Aurora Cannabis
$9.719876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$9.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.15 (-1.51%) Today
-$0.10 (-1.02%) After Hours
Why Robinhood?
You can buy or sell ACB and other stocks, options, ETFs, and crypto commission-free!
About
Aurora Cannabis Inc. Common Shares, also called Aurora Cannabis, is a Canada-based company engaged in the production and distribution of medical cannabis. Read More The firm is vertically integrated and horizontally diversified across every key segment of the value chain; from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. Its purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The company also produces and sells indoor cultivation systems and hemp related food products. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.
CEO
Employees
967
Headquarters
Edmonton, Alberta
Founded
2006
Market Cap
9.79B
Price-Earnings Ratio
â
Dividend Yield
0.00
Average Volume
12.38M
High Today
$9.95
Low Today
$9.51
Open Price
$9.78
Volume
17.01M
52 Week High
$12.53
52 Week Low
$4.05
Collections
Health
100 Most Popular
Most Popular Under $25
Pharmaceutical
Medical
Engineering
Food
2014 IPO
News
Seeking Alpha12h
What You Need To Know About Aurora Cannabis' Clinical Trials
Aurora Cannabis Inc (ACB) is a major Canadian cannabis producer operating across five continents. On February 11, 2019, ACB reported earnings for the quarter ending December 31, 2018. The company noted with earnings that it currently had "40 clinical trials and case studies completed or in progress," an achievement which forms part of the bull case on ACB. In this article I look into those clinical studies to see if there is indeed something to get excited about for ACB bulls or if these trials just represe...
Seeking Alpha13h
Aurora Cannabis' Investors Should Be Losing Sleep Over Its Dismal Financials
The winds of change are blowing as the coming financial quarters will see fundamentals increasingly take centre stage. Gross margins per gram is trending downwards on the back of an increase in the average selling price and cash costs per gram. Humpty Dumpty, the popular nursery rhyme taught to kids across the English speaking world foreshadows Aurora's (NYSE:ACB) future as the company continues along a trajectory characterized by substantial cash burn and a growing debt burden. Hence, while not fitting f...
InvestorPlace19h
Did You Miss Your Chance to Buy Aurora Cannabis (ACB) Stock?
Shares of Aurora Cannabis (NYSE: ACB ) have been soaring lately, up 25% in just a few trading sessions. Because of this giant move, investors are wondering if nowâs the time to get in on ACB stock or if a 25% rally means they missed their chance. Source: Shutterstock Whatâs the verdict? I wouldnât say thereâs no upside left, but the risk-reward profile has certainly muddied. Unfortunately, investors who are suffering a case of FOMO â a âfear of missing outâ â have no reason to be. There was ample time to...
Price Paid on Robinhood
25% Higher
Right Now
52 Week Low
$4.05
Average Price Paid
$7.78
52 Week High
$12.53
Earnings
-$0.18
-$0.09
$0.00
$0.09
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
â
Actual
Expected May 7, After Hours